Core Vct I Share Discussion Threads

[knowing] 06/3/2017 10:51

Confirmation RNS at THR now. Let's hope that the project delivers as Proactive states it could be a game changer

[nash81] 06/3/2017 10:16

sold my small IRG.

just topup JLP :)

[myst1] 06/3/2017 10:15

fillipe6 Mar '17 - 10:05 - 564806 of 564808
MTR + 11%....new RNS today 0938hrs.


MTR announced:

'Assays simply outstanding 'T3 resource which is several times wider than most copper deposits in the Kalahari copper belt'

CAF at MC of £2m hold 2 Licenses next door to MTR/Mod through JV with GET.
Exiting times ahead for CAF.

[fillipe] 06/3/2017 10:11

cpap man - DERR.

It's just a very short note - 1 x 2" column, mentioning the DERR Dec List with founder shareholders Nigel Wray, Stephen Helmsley and Hargreaves Hale.
Intends to move into medical products and devices.

No tp's mentioned or forecasts.

f

[fillipe] 06/3/2017 10:05

MTR + 11%....new RNS today 0938hrs.

f

[cpap man] 06/3/2017 09:51

ANGS



Looking very good now are ANGS

[cpap man] 06/3/2017 09:49

DERR



What did SCSW actually say about DERR then please fillipe?

[fillipe] 06/3/2017 09:47

GCM - a bit of a March hare there, since the start of this month.

f

[recordz] 06/3/2017 09:42

IRG look at the volume there.

[cpap man] 06/3/2017 09:41

DERR



Derriston - Nigel Wray-backed medical technology venture



Former Dominos boss Stephen Hemsley and serial investor Nigel Wray are backing a new venture in medical technology that will list on the London stock market next week after raising £2.3m from investors.

The company, Derriston Capital, will float as a cash shell with the aim of making its first acquisition in the med-tech space three to six months after listing.

Mr Wray, known as the Buffett of Britain, and Mr Hemsley, who is chief executive of Unitedhealth Group, each have an 8pc stake in the business, having invested £200,000 apiece.

The new business is also backed by property investor Warren Todd, through his vehicle Courtney Investments, and Harry Hyman, founder of Primary Health Properties, a real estate investment trust focused on healthcare. Other big-name investors include Hargreave Hale, which as a 10pc slice in Derriston.

Derriston’s finance director, Rodger Sargent, said Derriston’s first purchase would be a company, rather than a product, to give it instant scale, staff, infrastructure and a distribution network in which it can pump other products into.

The strategy is to find medical devices that are already on the market, but which are under-invested and unloved by their parent companies.

Derriston will acquire them into the cash shell through a reverse-takeover, outsource areas such as manufacturing, and ramp up sales to drive volume growth and bring costs down.

“These products are basically non-core to giant med-tech companies,” explained Mr Sargent. “If you have a product with X turnover, and others with 500 times X, you won’t focus on the smaller ones. But we can take those, give them some love and attention and greatly increase the distribution and sales.”

He said there was a growing market in the med-tech space for devices which are perhaps not the very best, but acceptable, lower-cost solutions for health authorities around the world which are coming under increasing strain from burgeoning and ageing populations.

“We have had a decent look around and nothing is definite yet but we have a wish list of companies we are interested in,” said Mr Sargent.

“Where we think we can really generate decent returns is getting into a particular genre or niche, be it by the technology type or the geographic region. The key will be forming relationships with distributors or clinics and sell a number of different products into the same distribution network. That is where operational gearing will come from.”

After the first acquisition, Derriston might consider moving to an Aim-listing, which would allow it to raise money through the tax-efficient Enterprise Investment Scheme as it looks to expand its portfolio and tap investors for more cash.

The shares will list on December 29.

[soulsauce] 06/3/2017 09:37

Definitely myst, no problem.

[soulsauce] 06/3/2017 09:27

myst you are right apart from one thing, the market cap is just over £2m, 83m shares in issue.

[myst1] 06/3/2017 09:23

CAF

Very little free float
Lithium play.
Copper play.
Significant board changes with industry experience in the last few weeks.
Name change in a couple of weeks.
Significantly under the radar less than £1m Market Cap

Definitely worth a look!

[knowing] 06/3/2017 09:15

Not released as yet

[ileeman] 06/3/2017 09:15

Good or bad?

[knowing] 06/3/2017 09:01

THR !! Trading halt in Aussie pending news

[daniel levi bmd] 06/3/2017 08:40

FYI




Dan
x

[nick rubens] 06/3/2017 08:36

CHAR has been in demand last couple of weeks and comfortably off it's lows. Drill coming early 2018 Morocco with Eni and payment due also(around £5m I think). Char also looking for two more potential big drills to do.

[ileeman] 06/3/2017 08:31

AAOG

Looks like it could be mega, producing and drills.

[cpap man] 06/3/2017 08:20

ANGS



ANGS could [oil] well more than double in the coming days and weeks to 25p+

[andrbea] 06/3/2017 08:19

good rns at fum (up 17%)

glr up again (up 5%)